Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings

Division of Cardiology, Stanford University School of Medicine, California 94305.

Annual coronary arteriograms have been obtained from all heart transplant recipients at Stanford University Medical Center since 1969. Angiographic lesions in 81 transplant patients exhibiting coronary vascular disease were classified into three categories: type A, discrete or tubular stenoses; type B, diffuse concentric narrowing; and type C, narrowed irregular vessels with occluded branches. The 81 arteriograms showing transplant coronary vascular disease were contrasted with 32 from nontransplant patients with coronary artery disease analyzed in a similar fashion. The nontransplant angiograms showed 178 lesions, all of type A (discrete or tubular) morphology, 75% of which were located in primary epicardial coronary vessels and 25% in secondary branch vessels. In the patients with transplant coronary vascular disease, 349 (76%) of 461 lesions were type A: 57% in primary vessels, 42% in secondary branches and 1.4% in tertiary branches. Of the 112 type B and C lesions (diffuse narrowing, tapering and obliteration), 25% were in primary vessels, 44% in secondary vessels and 31% in tertiary branches (p less than 0.05 for patients with transplant coronary vascular disease versus patients with nontransplant coronary artery disease). Total vessel occlusion was found in proximal or middle vessel segments in 96% and distally in 4% of patients with "ordinary" coronary artery disease versus 49% distally in patients with transplant coronary disease (p less than 0.002). In the presence of total vessel occlusion, collateral vessels were poor or absent in 92% of transplant versus 7% of nontransplant patients with coronary disease (p less than 0.002). Therefore, coronary artery disease in transplant patients represents a mixture of typical atheromatous lesions and unique transplant-related progressive distal obliterative disease that occurs without collateral vessel development.

This article has been cited by other articles:

				N. E. Hiemann, E. Wellnhofer, C. Knosalla, H. B. Lehmkuhl, J. Stein, R. Hetzer, and R. Meyer Prognostic Impact of Microvasculopathy on Survival After Heart Transplantation: Evidence From 9713 Endomyocardial Biopsies Circulation, September 11, 2007; 116(11): 1274 - 1282. [Abstract] [Full Text] [PDF]

				N. R. Bogot, R. Durst, D. Shaham, and D. Admon Cardiac CT of the Transplanted Heart: Indications, Technique, Appearance, and Complications RadioGraphics, September 1, 2007; 27(5): 1297 - 1309. [Abstract] [Full Text] [PDF]

				T. Caus Reply to mishra. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 863 - 864. [Full Text] [PDF]

				N. E. Hiemann, E. Wellnhofer, R. Meyer, H. Abdul-Khaliq, M. Dandel, O. Grauhan, M. Hummel, and R. Hetzer Prevalence of graft vessel disease after paediatric heart transplantation: a single centre study of 54 patients Interactive CardioVascular and Thoracic Surgery, October 1, 2005; 4(5): 434 - 439. [Abstract] [Full Text] [PDF]

				C. Hasdemir, K. Chandrasekaran, R. Lazzara, and D. W. Reynolds Sinus Node Dysfunction in a Heart Transplant Patient Secondary to Severe Sinus Node Artery Obstruction: A Case Report Angiology, November 1, 2003; 54(6): 725 - 728. [Abstract] [PDF]

				O. M. Muehling, N. M. Wilke, P. Panse, M. Jerosch-Herold, B. V. Wilson, R. F. Wilson, and L. W. Miller Reduced myocardial perfusion reserve and transmural perfusiongradient in heart transplant arteriopathyassessed by magnetic resonance imaging J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1054 - 1060. [Abstract] [Full Text] [PDF]

				A. Hognestad, K. Endresen, R. Wergeland, O. Stokke, O. Geiran, T. Holm, S. Simonsen, J. K. Kjekshus, and A. K. Andreassen Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients J. Am. Coll. Cardiol., August 6, 2003; 42(3): 477 - 482. [Abstract] [Full Text] [PDF]

				G. Vassalli, A. Gallino, M. Weis, W. von Scheidt, L. Kappenberger, L.K. von Segesser, J.-J. Goy, and on behalf of the Working Group Microcirculation of Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy Eur. Heart J., July 1, 2003; 24(13): 1180 - 1188. [Abstract] [Full Text] [PDF]

				D. X.-M. Zhao, Y. Hu, G. G. Miller, A. D. Luster, R. N. Mitchell, and P. Libby Differential Expression of the IFN-{gamma}-Inducible CXCR3-Binding Chemokines, IFN-Inducible Protein 10, Monokine Induced by IFN, and IFN-Inducible T Cell {alpha} Chemoattractant in Human Cardiac Allografts: Association with Cardiac Allograft Vasculopathy and Acute Rejection J. Immunol., August 1, 2002; 169(3): 1556 - 1560. [Abstract] [Full Text] [PDF]

				J. A. Shaw, B. A. Kingwell, A. S. Walton, J. D. Cameron, P. Pillay, C. D. Gatzka, and A. M. Dart Determinants of coronary artery compliance in subjects with and without angiographic coronary artery disease J. Am. Coll. Cardiol., May 15, 2002; 39(10): 1637 - 1643. [Abstract] [Full Text] [PDF]

				V. Marti, I. Romeo, R. Aymat, J. Garcia, P. Guiteras, M. Ballester, N. Aminian, J. M. Caralps, and J. M. Auge Coronary endothelial dysfunction as a predictor of intimal thickening in the long term after heart transplantation J. Thorac. Cardiovasc. Surg., December 1, 2001; 122(6): 1174 - 1180. [Abstract] [Full Text] [PDF]

				M. Dandel, M. Hummel, J. Muller, E. Wellnhofer, R. Meyer, N. Solowjowa, R. Ewert, and R. Hetzer Reliability of Tissue Doppler Wall Motion Monitoring After Heart Transplantation for Replacement of Invasive Routine Screenings by Optimally Timed Cardiac Biopsies and Catheterizations Circulation, September 18, 2001; 104(90001): I-184 - 191. [Abstract] [Full Text] [PDF]

				G.R Ciliberto, L Ruffini, M Mangiavacchi, M Parolini, R Sara, D Massa, R De Maria, E Gronda, E Vitali, and O Parodi Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation Eur. Heart J., June 1, 2001; 22(11): 964 - 971. [Abstract] [PDF]

				M Giulia Gagliardi, F Crea, B Polletta, C Bassano, G La Vigna, L Ballerini, and P Ragonese Coronary microvascular endothelial dysfunction in transplanted children Eur. Heart J., February 1, 2001; 22(3): 254 - 260. [Abstract] [PDF]

				X.-M. Zhao, Y. Hu, G. G. Miller, R. N. Mitchell, and P. Libby Association of Thrombospondin-1 and Cardiac Allograft Vasculopathy in Human Cardiac Allografts Circulation, January 30, 2001; 103(4): 525 - 531. [Abstract] [Full Text] [PDF]

				S. E. Nissen and P. Yock Intravascular Ultrasound : Novel Pathophysiological Insights and Current Clinical Applications Circulation, January 30, 2001; 103(4): 604 - 616. [Abstract] [Full Text] [PDF]

				J. M. Aranda Jr. and J. Hill Cardiac Transplant Vasculopathy Chest, December 1, 2000; 118(6): 1792 - 1800. [Abstract] [Full Text] [PDF]

				K Pethig, V Klauss, B Heublein, H Mudra, A Westphal, C Weber, K Theisen, and A Haverich Progression of cardiac allograft vascular disease as assessed by serial intravascular ultrasound: correlation to immunological and non-immunological risk factors Heart, November 1, 2000; 84(5): 494 - 498. [Abstract] [Full Text]

				J.-F. Legare, T. Issekutz, T. D. G. Lee, and G. Hirsch CD8+ T Lymphocytes Mediate Destruction of the Vascular Media in a Model of Chronic Rejection Am. J. Pathol., September 1, 2000; 157(3): 859 - 865. [Abstract] [Full Text] [PDF]

				S. Fateh-Moghadam, W. Bocksch, A. Ruf, T. Dickfeld, M. Schartl, G. Pogatsa-Murray, R. Hetzer, E. Fleck, and M. Gawaz Changes in Surface Expression of Platelet Membrane Glycoproteins and Progression of Heart Transplant Vasculopathy Circulation, August 22, 2000; 102(8): 890 - 897. [Abstract] [Full Text] [PDF]

				P. I. Hornick, P. D. Mason, R. J. Baker, M. Hernandez-Fuentes, L. Frasca, G. Lombardi, K. Taylor, L. Weng, M. L. Rose, M. H. Yacoub, et al. Significant Frequencies of T Cells With Indirect Anti-Donor Specificity in Heart Graft Recipients With Chronic Rejection Circulation, May 23, 2000; 101(20): 2405 - 2410. [Abstract] [Full Text] [PDF]

				P. Holvoet, J. Van Cleemput, D. Collen, and J. Vanhaecke Oxidized Low Density Lipoprotein Is a Prognostic Marker of Transplant-Associated Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 698 - 702. [Abstract] [Full Text] [PDF]

				G. G. Miller, S. F. Davis, J. B. Atkinson, D. B. Chomsky, P. Pedroso, V. S. Reddy, D. C. Drinkwater, X.-M. Zhao, and R. N. Pierson Longitudinal Analysis of Fibroblast Growth Factor Expression After Transplantation and Association With Severity of Cardiac Allograft Vasculopathy Circulation, December 14, 1999; 100(24): 2396 - 2399. [Abstract] [Full Text] [PDF]

				K. O. Akosah, B. Denlinger, and P. K. Mohanty Safety Profile and Hemodynamic Responses to {beta}-Adrenergic Stimulation by Dobutamine in Heart Transplant Patients* Chest, December 1, 1999; 116(6): 1587 - 1592. [Abstract] [Full Text] [PDF]

				D. A. Rossignol, B. Kipreos, K. Akosah, and P. K. Mohanty Accelerated Transplant Coronary Artery Disease and Massive Silent Acute Myocardial Infarction in a Heart Transplant Patient: A Case Report and Brief Review of Literature Angiology, November 1, 1999; 50(11): 947 - 953. [Abstract] [PDF]

				K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery) J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1262 - 1347. [Full Text] [PDF]

				H. A. Valantine, S.-Z. Gao, S. G. Menon, D. G. Renlund, S. A. Hunt, P. Oyer, E. B. Stinson, B. W. Brown Jr, T. C. Merigan, and J. S. Schroeder Impact of Prophylactic Immediate Posttransplant Ganciclovir on Development of Transplant Atherosclerosis : A Post Hoc Analysis of a Randomized, Placebo-Controlled Study Circulation, July 6, 1999; 100(1): 61 - 66. [Abstract] [Full Text] [PDF]

				S Fraund, K Pethig, U Franke, T Wahlers, W Harringer, J Cremer, H-G Fieguth, P Oppelt, and A Haverich Ten year survival after heart transplantation: palliative procedure or successful long term treatment? Heart, July 1, 1999; 82(1): 47 - 51. [Abstract] [Full Text] [PDF]

				T. Koyanagi, K. Minami, G. Tenderich, N. Reiss, M. Morshius, N. Mirow, and R. Korfer Thoracic and cardiovascular interventions after orthotopic heart transplantation Ann. Thorac. Surg., May 1, 1999; 67(5): 1350 - 1354. [Abstract] [Full Text] [PDF]

				T. L. Wolford, T. J. Donohue, R. G. Bach, J. H. Drury, E. A. Caracciolo, M. J. Kern, and L. W. Miller Heterogeneity of Coronary Flow Reserve in the Examination of Multiple Individual Allograft Coronary Arteries Circulation, February 9, 1999; 99(5): 626 - 632. [Abstract] [Full Text] [PDF]

				P.F. Ludman, F. Lazem, M. Barbir, and M. Yacoub Incidence and clinical relevance of coronary calcification detected by electron beam computed tomography in heart transplant recipients Eur. Heart J., February 2, 1999; 20(4): 303 - 308. [Abstract] [PDF]

				H. Holschermann, R. M. Bohle, H. Zeller, H. Schmidt, U. Stahl, L. Fink, H. Grimm, H. Tillmanns, and W. Haberbosch In Situ Detection of Tissue Factor within the Coronary Intima in Rat Cardiac Allograft Vasculopathy Am. J. Pathol., January 1, 1999; 154(1): 211 - 220. [Abstract] [Full Text] [PDF]

				S. R. Kapadia, S. E. Nissen, K. M. Ziada, V. Guetta, T. D. Crowe, R. E. Hobbs, R. C. Starling, J. B. Young, and E. M. Tuzcu Development of Transplantation Vasculopathy and Progression of Donor-Transmitted Atherosclerosis : Comparison by Serial Intravascular Ultrasound Imaging Circulation, December 15, 1998; 98(24): 2672 - 2678. [Abstract] [Full Text] [PDF]

				S. P. Jain, S. R. Ramee, C. J. White, M. R. Mehra, H. O. Ventura, S. Zhang, J. S. Jenkins, and T. J. Collins Coronary stenting in cardiac allograft vasculopathy J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1636 - 1640. [Abstract] [Full Text] [PDF]

				R. Lamich, M. Ballester, V. Marti, V. Brossa, R. Aymat, I. Carrio, L. Berna, M. Camprecios, M. Puig, M. Estorch, et al. Efficacy of augmented immunosuppressive therapy for early vasculopathy in heart transplantation J. Am. Coll. Cardiol., August 1, 1998; 32(2): 413 - 419. [Abstract] [Full Text] [PDF]

				K. Hoang, Y.-D. I. Chen, G. Reaven, L. Zhang, H. Ross, M. Billingham, and H. Valantine Diabetes and Dyslipidemia : A New Model for Transplant Coronary Artery Disease Circulation, June 2, 1998; 97(21): 2160 - 2168. [Abstract] [Full Text] [PDF]

				J. A. Jarcho and E. J. Mark Case 17-1998- A 53-Year-Old Man with Left Ventricular Dysfunction Four Years after a Heart Transplantation N. Engl. J. Med., May 28, 1998; 338(22): 1608 - 1616. [Full Text] [PDF]

				S. A. Hunt and O.H. Frazier Mechanical Circulatory Support and Cardiac Transplantation Circulation, May 26, 1998; 97(20): 2079 - 2090. [Full Text] [PDF]

				D. B. Cines, E. S. Pollak, C. A. Buck, J. Loscalzo, G. A. Zimmerman, R. P. McEver, J. S. Pober, T. M. Wick, B. A. Konkle, B. S. Schwartz, et al. Endothelial Cells in Physiology and in the Pathophysiology of Vascular Disorders Blood, May 15, 1998; 91(10): 3527 - 3561. [Full Text] [PDF]

				P. I. Hornick, P. D. Mason, M. H. Yacoub, M. L. Rose, R. Batchelor, and R. I. Lechler Assessment of the Contribution That Direct Allorecognition Makes to the Progression of Chronic Cardiac Transplant Rejection in Humans Circulation, April 7, 1998; 97(13): 1257 - 1263. [Abstract] [Full Text] [PDF]

				S. E. Reis, V. Bhoopalam, K. A. Zell, P. J. Counihan, A. J. C. Smith, S. Pham, and S. Murali Conjugated Estrogens Acutely Abolish Abnormal Cold-Induced Coronary Vasoconstriction in Male Cardiac Allografts Circulation, January 13, 1998; 97(1): 23 - 25. [Abstract] [Full Text] [PDF]

				P. Holvoet, J.-M. Stassen, J. Van Cleemput, D. Collen, and J. Vanhaecke Oxidized Low Density Lipoproteins in Patients With Transplant-Associated Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., January 1, 1998; 18(1): 100 - 107. [Abstract] [Full Text] [PDF]

				W. J. Paulus, S. Kastner, P. Pujadas, A. M. Shah, H. Drexler, and M. Vanderheyden Left Ventricular Contractile Effects of Inducible Nitric Oxide Synthase in the Human Allograft Circulation, November 18, 1997; 96(10): 3436 - 3442. [Abstract] [Full Text]

				T. T. Lim, D. H. Liang, J. Botas, J. S. Schroeder, S. N. Oesterle, and A. C. Yeung Role of Compensatory Enlargement and Shrinkage in Transplant Coronary Artery Disease: Serial Intravascular Ultrasound Study Circulation, February 18, 1997; 95(4): 855 - 859. [Abstract] [Full Text]

				J. Bartunek, A. M. Shah, M. Vanderheyden, and W. J. Paulus Dobutamine Enhances Cardiodepressant Effects of Receptor-Mediated Coronary Endothelial Stimulation Circulation, January 7, 1997; 95(1): 90 - 96. [Abstract] [Full Text]

				K. B. Lemstrom, A. K. Raisanen-Sokolowski, P. J. Hayry, and P. K. Koskinen Triple Drug Immunosuppression Significantly Reduces Aortic Allograft Arteriosclerosis in the Rat Arterioscler. Thromb. Vasc. Biol., April 1, 1996; 16(4): 553 - 564. [Abstract] [Full Text]

				S. F. Davis, A. C. Yeung, I. T. Meredith, F. Charbonneau, P. Ganz, A. P. Selwyn, and T. J. Anderson Early Endothelial Dysfunction Predicts the Development of Transplant Coronary Artery Disease at 1 Year Posttransplant Circulation, February 1, 1996; 93(3): 457 - 462. [Abstract] [Full Text]

				Y. Furukawa, A. Matsumori, T. Hirozane, and S. Sasayama Angiotensin II Receptor Antagonist TCV-116 Reduces Graft Coronary Artery Disease and Preserves Graft Status in a Murine Model : A Comparative Study With Captopril Circulation, January 15, 1996; 93(2): 333 - 339. [Abstract] [Full Text]

				P. R. Rickenbacher, F. J. Pinto, N. P. Lewis, S. A. Hunt, E. L. Alderman, J. S. Schroeder, E. B. Stinson, B. W. Brown, and H. A. Valantine Prognostic Importance of Intimal Thickness as Measured by Intracoronary Ultrasound After Cardiac Transplantation Circulation, December 15, 1995; 92(12): 3445 - 3452. [Abstract] [Full Text]

				E. A. Caracciolo, T. L. Wolford, R. D. Underwood, T. J. Donohue, R. G. Bach, L. W. Miller, and M. J. Kern Influence of Intimal Thickening on Coronary Blood Flow Responses in Orthotopic Heart Transplant Recipients : A Combined Intravascular Doppler and Ultrasound Imaging Study Circulation, November 1, 1995; 92(9): 182 - 190. [Abstract] [Full Text]

				K. Lemstrom, P. Koskinen, L. Krogerus, M. Daemen, C. Bruggeman, and P. Hayry Cytomegalovirus Antigen Expression, Endothelial Cell Proliferation, and Intimal Thickening in Rat Cardiac Allografts After Cytomegalovirus Infection Circulation, November 1, 1995; 92(9): 2594 - 2604. [Abstract] [Full Text]

				C. A. Labarrere, D. Pitts, D. R. Nelson, and W. P. Faulk Vascular Tissue Plasminogen Activator and the Development of Coronary Artery Disease in Heart-Transplant Recipients N. Engl. J. Med., October 26, 1995; 333(17): 1111 - 1116. [Abstract] [Full Text] [PDF]

				W. J. Paulus, P. J. Vantrimpont, and A. M. Shah Paracrine Coronary Endothelial Control of Left Ventricular Function in Humans Circulation, October 15, 1995; 92(8): 2119 - 2126. [Abstract] [Full Text]

				J. Botas, F. J. Pinto, A. Chenzbraun, D. Liang, J. S. Schroeder, S. N. Oesterle, E. L. Alderman, R. L. Popp, and A. C. Yeung Influence of Preexistent Donor Coronary Artery Disease on the Progression of Transplant Vasculopathy : An Intravascular Ultrasound Study Circulation, September 1, 1995; 92(5): 1126 - 1132. [Abstract] [Full Text]

				J. D. Hosenpud, J. P. Everett, T. E. Morris, K. A. Mauck, G. D. Shipley, and C. R. Wagner Cardiac Allograft Vasculopathy : Association With Cell-Mediated but Not Humoral Alloimmunity to Donor-Specific Vascular Endothelium Circulation, July 15, 1995; 92(2): 205 - 211. [Abstract] [Full Text]

				B. Hausen, J. M. Albes, R. Rohde, S. Demertzis, A. Mugge, and H.-J. Schafers Tricuspid Valve Regurgitation Attributable to Endomyocardial Biopsies and Rejection in Heart Transplantation Ann. Thorac. Surg., May 1, 1995; 59(5): 1134 - 1140. [Abstract] [Full Text]

				M. C. Deng, S. Bell, P. Huie, F. Pinto, S. A. Hunt, E. B. Stinson, R. Sibley, B. M. Hall, and H. A. Valantine Cardiac Allograft Vascular Disease : Relationship to Microvascular Cell Surface Markers and Inflammatory Cell Phenotypes on Endomyocardial Biopsy Circulation, March 15, 1995; 91(6): 1647 - 1654. [Abstract] [Full Text]

				T. Hirozane, A. Matsumori, Y. Furukawa, and S. Sasayama Experimental Graft Coronary Artery Disease in a Murine Heterotopic Cardiac Transplant Model Circulation, January 15, 1995; 91(2): 386 - 392. [Abstract] [Full Text]

				J. S. Schroeder, S.-Z. Gao, E. L. Alderman, S. A. Hunt, I. Johnstone, D. B. Boothroyd, V. Wiederhold, and E. B. Stinson A Preliminary Study of Diltiazem in the Prevention of Coronary Artery Disease in Heart-Transplant Recipients N. Engl. J. Med., January 21, 1993; 328(3): 164 - 170. [Abstract] [Full Text]